Momentum Monday: The Comeback Of Biotech?

Published 09/04/2018, 12:26 AM
Updated 07/09/2023, 06:31 AM
IBB
-
AAPL
-
AMZN
-
XBI
-

The bull market continues to rage with full force. Apple (NASDAQ:AAPL) has been unstoppable after its earnings gap and it’s already a 1.1-trillion-dollar company. It is looking extended to chase here. Amazon (NASDAQ:AMZN) is less than 2% away from becoming the next trillion-dollar company.

We continue to see strength in enterprise software, semiconductors, cybersecurity, retailers, and more recently – biotech. After quadrupling between 2012 and 2015, the biotech ETF, iShares Nasdaq Biotechnology (NASDAQ:IBB) has spent the last four years building a new base and it is not too far from making new all-time highs. The smaller-cap biotech ETF, SPDR S&P Biotech (NYSE:XBI) has already passed that milestone. The renewed interest in marijuana stocks has brought new life to the whole biotech sector. It might remain in play for a long time.

Latest comments

Loading next article…
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.